强生Johnson & Johnson (JNJ) 2022年CSR报告「NYSE」.pdf

1、2022 Health for Humanity ReportScientist Jan G.is shown working in Johnson&Johnsons molecule library,which stores more than 1.7 million unique compounds.Our scientists can access this library to order compounds for R&D activities at Johnson&Johnson.Photo by Frederik Beyens.2022 Health for Humanity R

2、eport2 2Diverse Surgeon Initiative 2.0 participants Ryan Randle,M.D.,and Michelle Salazar,M.D.,M.H.Sc.,participate in a laparoscopic surgery hands-on lab.Our ApproachGlobal Health Equity Our Employees Environmental Health Accountability&Innovation Reporting Hub Our Approach Message From Our Chairman

3、&CEOQ&A With Our Lead DirectorYear in BriefAbout Johnson&JohnsonESG GovernanceHealth for Humanity 2025 GoalsAbout This Report2022 Health for Humanity Report3Leading with accountability and innovation.Grounded in the belief that science and technology will advance healthcare more in this decade than

4、in the last century,we invested nearly$15 billion in R&D in 2022 and integrated digital capabilities into how we work.Data science is also applied to our R&D ecosystem of medical devices,software and robotics solutions,helping healthcare providers care for patients with greater precision and efficie

5、ncy.Following the acquisition of Abiomed,Inc.,the world leader in heart recovery solutions,we are integrating their technology and expanding our leadership in cardiovascular care.Technology is also helping our supply chain make leaps forward in productivity,efficiency and sustainability.This fact wa

6、s recognized by the World Economic Forum,which has granted 11(three new in 2022)Lighthouse designations to our manufacturing facilities.As we reflect on 2022s accomplishments,we do so with an eye to a different but no less exciting future.In 2023,we are on track to advance two global companies:Kenvu